Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

19.51
Delayed Data
As of 12:28pm ET
 -0.15 / -0.76%
Today’s Change
7.56
Today|||52-Week Range
23.57
+2.58%
Year-to-Date

Today’s Trading

Previous close19.66
Today’s open19.78
Day’s range19.51 - 19.81
Volume65,322
Average volume (3 months)341,228
Market cap$612.0M
Dividend yield--
Data as of 12:28pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-9.14%
Earnings growth (this year)-25.86%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.08

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc-0.07-0.58%
----
RVNCRevance Therapeutics...-0.50-2.38%
ACHNAchillion Pharmaceut...-0.07-1.61%
Data as of 12:30pm ET, 02/22/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$46.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Senior Vice President-
CMC Operations
Dan Leblanc
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs